The prohibition of kidney sales and organ markets should remain

Current Opinion in Organ Transplantation

Volumn 13, Issue 4, 2008, Pages 386-394

  Danovitch, Gabriel M ^a   Delmonico, Francis L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Living kidney donation; Organ vending; Transplant ethics; Transplant infections

Indexed keywords

CADAVER KIDNEY; CLINICAL TRIAL; COAL WORKER; DOCTOR PATIENT RELATION; FIRE FIGHTER; GRAFT RECIPIENT; HEALTH CARE POLICY; HUMAN; INSURANCE; INTERNET; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LAW; LIVING DONOR; MARKETING; MULTICENTER STUDY; ORGAN DONOR; ORGAN PRESERVATION; REVIEW; UNITED STATES;

ALTRUISM; COST-BENEFIT ANALYSIS; CRIME; FINANCING, ORGANIZED; GIFT GIVING; GOVERNMENT REGULATION; HEALTH CARE COSTS; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MOTIVATION; ORGANIZATIONAL OBJECTIVES; PUBLIC OPINION; RENAL DIALYSIS; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 58449118590     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3283097476     Document Type: Review

References (37)

1. Shimazono, Y. Mapping "Transplant Tourism." Presentation at the World Health Organization's Second Global Consultation on Human Transplantation; 28-30 March 2007; Geneva.
2. Budiani DA, Delmonico FL. Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant 2008; 8:925-929.
3. Naqvi A. A socio-economic survey of kidney vendors in Pakistan. Transpl Int 2007; 20:909-992.
4. Delmonico FL. The Pakistani revelation. Transpl Int 2007; 20:924-925.
5. Radcliffe-Richards J. Nepharious goings on: kidney sales and moral arguments. J Med Philos 1996; 21:375-416.
6. Epstein M. The ethics of poverty and the poverty of ethics: the case of Palestinian prisoners in Israel seeking to sell their kidneys in order to feed their children. J Med Ethics 2007; 33:473-474.
7. Hughes P. Social constraint, emergent goods, and human kidney markets. J Value Inqu 2006; 49:323-340.
8. Danovitch GM. The doctor-patient relationship in living donor kidney transplantation. Curr Opin Nephrol Hypertens 2007; 16:503-505.
9. Davis CL, Delmonico FL. Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005; 16:2098.
10. Delmonico F; Council of the Transplantation Society. A Report of the Amsterdam Forum on the Care of the Live Kidney Donor: Data and Medical Guidelines. Transplantation 2005; 79 (Suppl 6):S53-S66.
11. Dew MA, Jacobs CL, Jowsey SG, et al., United Network for Organ Sharing (UNOS); American Society of Transplant Surgeons; American Society of Transplantation. Guidelines for the psychosocial evaluation of living unrelated kidney donors in the United States. Am J Transplant 2007; 5:1047-1054.
12. Danovitch G. Who cares? The doctor/patient relationship in living kidney donation. In: Weimar W, Bos MA, Busschbach JJ, editors. Organ transplantation: ethical, legal and psychosocial aspects. Lengerich, Germany: Pabst Science Publishers; 2008. pp. 49-54.
13. Clemens KK, Thiessen-Philbrook H, Parikh CR, et al. Psychosocial health of living kidney donors: a systematic review. Am J Transplant 2006; 6:2965.
14. Prasad GV, Shukla A, Huang M, et al. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation 2006; 82:1130-1135.
15. Rizvi S, Naqvi S, Zafar M, et al. Health function and renal function evaluation of kidney venders: a report from Pakistan. Am J Transplant Epub ahead of print. doi:10.1111/j.1600-6143.2008.02265.x
16. Goyal M, Mehta RL, Schneiderman LJ, et al. Economic and health consequences of selling a kidney in India. JAMA 2002; 288:1589-1593.
17. Jha V, Chugh KS. The case against a regulated system of living kidney sales. Nat Clin Pract Nephrol 2006; 2:466.
18. Ghods AS. Iranian model of paid and regulated living-unrelated kidney donation. Clin J Am Soc Nephrol 2006; 1:1136-1139.
19. Zargooshi J. Iranian kidney donors: motivations and relations with recipients. J Urol 2001; 165:386-392.
20. Zargooshi J. Iran's Commercial Renal Transplantation Program: results and complications. In: Weimar W, Bos MA, Busschbach JJ, editors. Organ transplantation: ethical, legal and psychosocial aspects. Lengerich, Germany: Pabst Science Publishers; 2008. pp. 80-92.
21. Delmonico FL, Surman O. Is this living donor your patient. Transplantation 2003; 76:1257-1260.
22. Adams PL, Cohen D, Danovitch G, et al. The nondirected live-kidney donor: ethical considerations and practice guidelines. Transplantation 2002; 74: 582-590.
23. Commonwealth of Massachusetts, Superior Court Civil Action (Worcester) No. 03-00557.
24. Matas A. A Gift of Life Deserves Compensation. How to Increase Living Kidney Donation with Realistic Incentives. The Cato Institute Policy Analysis No. 604; 7 November 2007.
25. Delmonico FL, Graham WK. Direction of the Organ Procurement and Transplantation Network and United Network for Organ Sharing regarding the oversight of live donor transplantation and solicitation for organs. Am J Transplant 2006; 6:37-40.
26. Childress J, Liverman C, editors. Organ donation: opportunities for action. Washington, DC: National Academies Press; 2006.
27. Delmonico F. The transplant donor payment debate. Kidney Int 2006; 70: 605-606.
28. Danovitch G, Leichtman A. Kidney vending: the 'Trojan horse' of organ transplantation. Clin J Am Soc Nephrol 2006; 1:1133.
29. Danovitch GM. Cultural barriers to kidney transplantation: a new frontier. Transplantation 2007; 84:462-464.
30. Roth A. Repugnance as a Constraint on Markets. J Econ Perspect 2007; 21:37-58.
31. Phillips K. Getting stuck on Iraq. New York Times. 31 October 2006.
32. Danovitch GM. From Helsinki to Istanbul: what can the transplant community learn from experience in clinical research? Nephrol Dial Transplant 2008; 23:1089-1092.
33. Goodyear MD, Krlaza-Jeric K, Lemmens T. The Declaration of Helsinki. BMJ 2007; 335:624-625.
34. Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999; 341:198.
35. Bentley J. The influence of risk and monetary payment on the research participation decision-making process. J Med Ethics 2007; 30:293.
36. Schulz-Baldes A, Delmonico FL. Improving institutional fairness to live kidney donors: donor needs must be addressed by safeguarding donation risks and compensating donation costs. Transpl Int 2007; 20:940-946.
37. Shapiro M. The development of a new allocation algorithm for deceased donor kidneys. Curr Opin Nephrol Hypertens 2007; 16:512-515.